Shares of obesity drug developer Aardvark Therapeutics (NASDAQ:AARD) closed 11% lower following a $94M initial public offering. Read more here.

For example, quote pages like this one allows you to chart a stock's progress, examine in-depth financials, read its latest announcements and much more to help you make informed decisions.

Kilroy Realty Corporation (NYSE: KRC, the “Company”, “Kilroy”) is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and ...

Petroleo Brasileiro S/A Ord 0.28% R$485.32B Petroleo Brasileiro S/A Pref 0.11% R$485.32B ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...